Impact Factor
7.883
Call For Paper
Volume 12 Issue 07
July 2026
Download Paper Format
Copyright Form
Author(s)
Sandip D Pagare Andhale A.K Kamble H.V.
Abstract
Covishield (ChAdOx1-nCOV Or AZD1222) Is A Recombinant, Replication-deficient Chimpanzee Adenovirus Vector Encoding The SARS-CoV-2 S Glycoprotein Vaccine Currently Being Developed By The Serum Institute Of India (SII), Pune, Based On The AstraZeneca-Oxford
Keywords
Covishield
Vaccine Effectiveness
Test-negative Design
Paper ID
IJSARTV8I1156971
Publication Date
November 23, 2022
Research Area
Vaccine